ctrl K

Watchlist Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

10.49

-0.36 (-3.32%)

At close: Jun 17, 2025, 1:50 PM

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-10.47M	-9.45M	-5.09M	-2.23M	-1.72M
Interest Income	n/a	717K	1M	118K	135K
Pretax Income	-9.31M	-8.78M	-4.18M	-2.04M	-2.11M
Net Income	-9.31M	-8.78M	-4.18M	-2.04M	-2.11M
Selling & General & Admin	2.71M	1.39M	1.03M	525K	538K
Research & Development	7.75M	8.06M	4.07M	1.54M	964K
Other Expenses	n/a	n/a	n/a	171K	217K
Operating Expenses	10.47M	9.45M	5.09M	2.23M	1.72M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	9.45M	5.09M	2.23M	1.72M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.19M	12.91M	12.91M	9.73M	9.73M
Shares Outstanding (Diluted)	13.19M	12.91M	12.91M	9.73M	9.73M
EPS (Basic)	-0.71	-0.68	-0.32	-0.21	-0.22
EPS (Diluted)	-0.71	-0.68	-0.32	-0.21	-0.22
EBITDA	-10.47M	-9.45M	-5M	-2.02M	-1.48M
EBIT	n/a	-8.78M	-5.09M	-2.06M	-1.5M
Depreciation & Amortization	n/a	-121K	87K	25K	26K